PATENT CLAIM ANALYSIS

Application Number: 15956931
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "078040"]

Abstract:
The invention provides contact lens and contact lens storage compositions and methods for the treatment of presbyopia. The contact lens and contact lens storage compositions preferably comprise aceclidine and a cryoprotectant. The compositions optionally contain a cycloplegic agent.

Claim (Index 9):
The composition of  claim 8 , wherein the compound for the treatment of presbyopia is selected from a muscarinic agonist and an anti-cross linking agent and the cryoprotectant is selected from the group consisting of a polyol, a sugar, an alcohol, a lower alkanol, a lipophilic solvent, a hydrophilic solvent, a bulking agent, a solubilizer, a surfactant, an antioxidant, a cyclodextrin, a maltodextrin, colloidal silicon dioxide, polyvinyl alcohol, glycine, 2-methyl-2,4-pentanediol, cellobiose, gelatin, polyethylene glycol (PEG), dimethyl sulfoxide (DMSO), formamide, antifreeze protein 752 or a combination thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.70833
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15235431', '14742921', '15864703', '14742903', '14223639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8132949582289719
- 35 USC 102 Novelty (BERT): 0.5791562418399177
- Combined Prediction Score: 0.7898810865900665
- Mean Citation Score: 474.735712
- Max Citation Score: 482.30646
- Similarity Product: 409.38758948172926

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test